Real Value Shared with the Global Community

Belong
provides

True value for the global
community

Belong provides true value for the global community

Revealing hidden patterns using Belong’s proprietary, multi-layered data powered by machine learning & artificial intelligence to advance clinical research and improve patient quality of life and care. For patients, caregivers, health professionals, providers and pharma.

We are deeply committed to advancing the state of global research with quality, real-world data.

Leveraging AI & ML
for a Hyper-Personalized
Experience

Cutting-edge AI, machine learning and proprietary medical
neural networks are changing the way we and our partners
understand patient journeys.

Why conduct research with Belong?

Highly engaged patients
Disruptive analytics technologies
Unparalleled real-world data​​

Belong.life Can Help You Accelerate Research

By understanding real-life treatment journeys, analyzing critical decision points, conducting surveys, and providing you with competitive Business Intelligence.

Recent Studies

We have made significant contributions to global cancer research, having published several papers in leading international peer-reviewed journals.

Behavioral practices of cancer patients: misconceptions compromising daily life activities

Cancer patients’ real-world-behavior reveals compromised daily life activities, and more.

Covid 19 Vaccines In Cancer Patients

Researched by Belong.Life and published by ASCO
1069 patients, users of Belong.life, a worldwide, free, and voluntary, digital health application,
replied during April 2021 to a targeted survey including demographic & clinical questions
related to their cancer status, ongoing therapies and the received Covid 19 vaccination details

Using a digital patient powered research network to identify outcomes of importance to patients with multiple myeloma

2020
Social media platforms give patients a voice by allowing them to discuss their health and connect with others. These unfiltered and genuine reports offer direct access to what matters most to patients. Exploring the patient-reported outcomes discussed in these platforms reveal clinical insights and behavioral patterns of the real-world patient journey. This research study reviewed health-related quality of life (HRQoL) concepts reported by patients with multiple myeloma (MM).

Advanced Breast Cancer Patients, Focusing On Patient’s Reported Outcomes In Reducing The Burden Of Financial Toxicity

2019
A targeted survey of Belong.life Advanced Breast Cancer (ABC) patients (pts), focusing on patient’s reported outcomes (PROs), real world evidence (RWE) and insights in reducing the burden of financial toxicity (FT)

Unveiling The Real-World Outcomes Of Breast Cancer Patients With Taxanes-Induced Neuropathy Using A Digital Patient-Powered Network

Researched by Belong.Life and published by ASCO
Taxanes-induced neuropathy is common in BC patients receiving taxanes, forcing dose reductions and treatment delays and posing serious challenges for the long-term patient QoL….

Skip to content